Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China

Affiliations

• ¹ Department of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
• ² Department of Medical Oncology, Xi 'an No.3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, China.
• ³ Department of Oncology, Xi'an International Medical Center Hospital, Xi'an, China.
• ⁴ Department of Medical Oncology, Qinghai Provincial Cancer Hospital, Fifth People's Hospital of Qinghai Province, Xi'an, China.
• ⁵ Department of Medical Oncology, Yan'an University Affiliated Hospital, Yan'an, China.
• ⁶ Department of Medical Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, China.
• ⁷ Department of Medical Oncology, Baoji Central Hospital, Baoji, China.
• ⁸ Department of Medical Oncology, Hanzhong Central Hospital, Hanzhong, China.
• ⁹ 4th Department of Oncology, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
• ¹⁰ Department of Respiratory and Critical Care Medicine, Xi 'an No.3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, China.
• ¹¹ Department of Medical Oncology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
• ¹² Department of Pulmonary Medicine, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.
• ¹³ Department of Respiratory Medicine, Xianyang Central Hospital, Xianyang, China.
• ¹⁴ Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
• ¹⁵ Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Xi'an, China.
• ¹⁶ Bioinspired Engineering and Biomechanics Center, Xi'an Jiaotong University, Xi'an, China.